Cargando…
Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics
The liver is a vital organ that plays a crucial role in the physiological operation of the human body. The liver controls the body’s detoxification processes as well as the storage and breakdown of red blood cells, plasma protein and hormone production, and red blood cell destruction; therefore, it...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057127/ https://www.ncbi.nlm.nih.gov/pubmed/36985782 http://dx.doi.org/10.3390/molecules28062811 |
_version_ | 1785016285982097408 |
---|---|
author | Singh, Sukhbir Sharma, Neelam Shukla, Saurabh Behl, Tapan Gupta, Sumeet Anwer, Md. Khalid Vargas-De-La-Cruz, Celia Bungau, Simona Gabriela Brisc, Cristina |
author_facet | Singh, Sukhbir Sharma, Neelam Shukla, Saurabh Behl, Tapan Gupta, Sumeet Anwer, Md. Khalid Vargas-De-La-Cruz, Celia Bungau, Simona Gabriela Brisc, Cristina |
author_sort | Singh, Sukhbir |
collection | PubMed |
description | The liver is a vital organ that plays a crucial role in the physiological operation of the human body. The liver controls the body’s detoxification processes as well as the storage and breakdown of red blood cells, plasma protein and hormone production, and red blood cell destruction; therefore, it is vulnerable to their harmful effects, making it more prone to illness. The most frequent complications of chronic liver conditions include cirrhosis, fatty liver, liver fibrosis, hepatitis, and illnesses brought on by alcohol and drugs. Hepatic fibrosis involves the activation of hepatic stellate cells to cause persistent liver damage through the accumulation of cytosolic matrix proteins. The purpose of this review is to educate a concise discussion of the epidemiology of chronic liver disease, the pathogenesis and pathophysiology of liver fibrosis, the symptoms of liver fibrosis progression and regression, the clinical evaluation of liver fibrosis and the research into nanotechnology-based synthetic and herbal treatments for the liver fibrosis is summarized in this article. The herbal remedies summarized in this review article include epigallocathechin-3-gallate, silymarin, oxymatrine, curcumin, tetrandrine, glycyrrhetinic acid, salvianolic acid, plumbagin, Scutellaria baicalnsis Georgi, astragalosides, hawthorn extract, and andrographolides. |
format | Online Article Text |
id | pubmed-10057127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100571272023-03-30 Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics Singh, Sukhbir Sharma, Neelam Shukla, Saurabh Behl, Tapan Gupta, Sumeet Anwer, Md. Khalid Vargas-De-La-Cruz, Celia Bungau, Simona Gabriela Brisc, Cristina Molecules Review The liver is a vital organ that plays a crucial role in the physiological operation of the human body. The liver controls the body’s detoxification processes as well as the storage and breakdown of red blood cells, plasma protein and hormone production, and red blood cell destruction; therefore, it is vulnerable to their harmful effects, making it more prone to illness. The most frequent complications of chronic liver conditions include cirrhosis, fatty liver, liver fibrosis, hepatitis, and illnesses brought on by alcohol and drugs. Hepatic fibrosis involves the activation of hepatic stellate cells to cause persistent liver damage through the accumulation of cytosolic matrix proteins. The purpose of this review is to educate a concise discussion of the epidemiology of chronic liver disease, the pathogenesis and pathophysiology of liver fibrosis, the symptoms of liver fibrosis progression and regression, the clinical evaluation of liver fibrosis and the research into nanotechnology-based synthetic and herbal treatments for the liver fibrosis is summarized in this article. The herbal remedies summarized in this review article include epigallocathechin-3-gallate, silymarin, oxymatrine, curcumin, tetrandrine, glycyrrhetinic acid, salvianolic acid, plumbagin, Scutellaria baicalnsis Georgi, astragalosides, hawthorn extract, and andrographolides. MDPI 2023-03-20 /pmc/articles/PMC10057127/ /pubmed/36985782 http://dx.doi.org/10.3390/molecules28062811 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Singh, Sukhbir Sharma, Neelam Shukla, Saurabh Behl, Tapan Gupta, Sumeet Anwer, Md. Khalid Vargas-De-La-Cruz, Celia Bungau, Simona Gabriela Brisc, Cristina Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics |
title | Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics |
title_full | Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics |
title_fullStr | Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics |
title_full_unstemmed | Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics |
title_short | Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics |
title_sort | understanding the potential role of nanotechnology in liver fibrosis: a paradigm in therapeutics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057127/ https://www.ncbi.nlm.nih.gov/pubmed/36985782 http://dx.doi.org/10.3390/molecules28062811 |
work_keys_str_mv | AT singhsukhbir understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT sharmaneelam understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT shuklasaurabh understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT behltapan understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT guptasumeet understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT anwermdkhalid understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT vargasdelacruzcelia understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT bungausimonagabriela understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics AT brisccristina understandingthepotentialroleofnanotechnologyinliverfibrosisaparadigmintherapeutics |